ONELZA
Table of contents:
| Trademark domain | |
| name | is free? |
|---|---|
| onelza.com |  |
The "ONELZA" trademark, serial number 78851346 , was filed on 31st of March 2006 with a mark drawing code of 4000 and its transaction date is 78851346. The attorney assigned is Christopher L. Graff, attorney docket number VPBV002. Since 28th of January 2014, the document can be found in the L20 law office in the publication and issue section. The employee responsible is WEBSTER, WILLIAM M and the date it was published for opposition on 11/27/2007. The status of the trademark was checked last on 11/26/2012.
Other trademarks by this attorney include , WORLD CUP 2014 . The corresponded responsible for this trademark is Christopher L. Graff, located at PIRKEY BARBER PLLC, 600 Congress Ave., Suite 2120, Austin TX 78701.The state or country where the trademark was organized is by Valeant International (barbados) Srl. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Welches, Christ Church, zip BB17154 and also by Biovail Laboratories International Srl - Other (Indicates Entity-Statement should appear)., located at Welches, Christ Church, zip BB17154.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 04/06/2006 |
| Primary Code | 005 |
| Goods codes | |
| GS0051 | Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking excluding pharmaceutical preparations and substances delivered by transdermal plasters or transdermal patches; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, anti-inflammatories and pain relief medication excluding pain relief medication delivered by transdermal plasters or transdermal patches; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 01/22/2014 | ATTORNEY REVOKED AND/OR APPOINTED | I - Incoming Correspondence | ARAA - ATTORNEY REVOKED AND/OR APPOINTED | |
| 01/22/2014 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED | I - Incoming Correspondence | REAP - TEAS REVOKE/APPOINT ATTORNEY RECEIVED | |
| 11/26/2012 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
| 11/26/2012 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
| 08/01/2012 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 05/04/2012 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 05/03/2012 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
| 04/24/2012 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
| 04/24/2012 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 10/20/2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 10/19/2011 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
| 10/17/2011 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
| 10/17/2011 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 04/19/2011 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 04/18/2011 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
| 04/13/2011 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
| 04/13/2011 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 04/06/2011 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 03/23/2011 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 10/16/2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 10/15/2010 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
| 09/29/2010 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
| 10/15/2010 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
| 10/13/2010 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 09/29/2010 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 04/16/2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | E | EXRA | |
| 04/14/2010 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
| 04/14/2010 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
| 04/14/2010 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 10/27/2009 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
| 09/15/2009 | TTAB RELEASE CASE TO TRADEMARKS | T - TTAB Proceeding | TMBN | |
| 09/15/2009 | OPPOSITION TERMINATED NO. 999999 | T - TTAB Proceeding | OP.T - OPPOSITION TERMINATED NO. 999999 | |
| 09/15/2009 | OPPOSITION DISMISSED NO. 999999 | T - TTAB Proceeding | OP.D - OPPOSITION DISMISSED NO. 999999 | |
| 08/14/2009 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
| 06/17/2009 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 01/22/2009 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | I - Incoming Correspondence | CHAN - APPLICANT CHANGES (NON-RESPONSIVE) ENTERED | |
| 01/22/2009 | TEAS CHANGE OF OWNER ADDRESS RECEIVED | I - Incoming Correspondence | COAR - TEAS CHANGE OF OWNER ADDRESS RECEIVED | |
| 03/26/2008 | OPPOSITION INSTITUTED NO. 999999 | T - TTAB Proceeding | OP.I - OPPOSITION INSTITUTED NO. 999999 | |
| 12/14/2007 | EXTENSION OF TIME TO OPPOSE RECEIVED | T - TTAB Proceeding | ETOF - EXTENSION OF TIME TO OPPOSE RECEIVED | |
| 12/07/2007 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | I - Incoming Correspondence | CHPB - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | |
| 11/30/2007 | FAX RECEIVED | I - Incoming Correspondence | FAXX - FAX RECEIVED | |
| 11/27/2007 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 11/07/2007 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
| 10/19/2007 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 10/19/2007 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 09/29/2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 09/18/2007 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 09/13/2007 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 09/12/2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 09/12/2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 09/12/2007 | TEAS REQUEST FOR RECONSIDERATION RECEIVED | I - Incoming Correspondence | ERFR | |
| 03/14/2007 | FINAL REFUSAL E-MAILED | O - Outgoing Correspondence | GNFR - FINAL REFUSAL E-MAILED | |
| 03/14/2007 | FINAL REFUSAL WRITTEN | R - Renewal | CNFR - FINAL REFUSAL WRITTEN | |
| 03/13/2007 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 03/13/2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 03/13/2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 09/13/2006 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 09/13/2006 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 09/13/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 04/06/2006 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.